CRDF - Cardiff Oncology, Inc. -  [ ]

Ticker Details
Cardiff Oncology, Inc.
IPO Date: August 1, 2004
Sector: Healthcare
Industry: Biotech
Market Cap: $108.45M
Activated in VL: True
Average Daily Range
Avg Daily Range: $0.18 | 4.08%
Avg Daily Range (30 D): $0.07 | 3.38%
Avg Daily Range (90 D): $0.07 | 3.19%
Institutional Daily Volume
Avg Daily Volume: .95M
Avg Daily Volume (30 D): 1.32M
Avg Daily Volume (90 D): 1.02M
Trade Size
Avg Trade Size (Sh.): 177
Avg Trade Size (Sh.) (30 D): 238
Avg Trade Size (Sh.) (90 D): 212
Institutional Trades
Total Institutional Trades: 177
Avg Institutional Trade: $2.01M
Avg Institutional Trade (30 D): $.63M
Avg Institutional Trade (90 D): $1.11M
Avg Institutional Trade Volume: .26M
Avg Institutional Trades (Per Day): 1
Market Closing Trades
Avg Closing Trade: $3.1M
Avg Closing Trade (30 D): $.63M
Avg Closing Trade (90 D): $.63M
Avg Closing Volume: 376.13K
 
News
Nov 24, 2025 @ 12:00 PM
Cardiff Oncology to Present at the Piper Sandler 3...
Source: Cardiff Oncology, Inc.
Nov 12, 2025 @ 6:00 PM
KRAS Inhibitors Market to Witness Explosive Growth...
Source: Delveinsight
Mar 8, 2025 @ 12:33 PM
Why the Global Cancer Market Could Surpass $900 Bi...
Source: Prnewswire
Dec 10, 2024 @ 12:20 PM
Cardiff Oncology Prices Oversubscribed $40 Million...
Source: Globe Newswire
Dec 10, 2024 @ 11:00 AM
Cardiff Oncology Announces Positive Initial Data f...
Source: N/A
Financials
  TTM Q2 2025 Q1 2025
Basic EPS $-.17 $-.21 $-.2
Diluted EPS $-.17 $-.21 $-.2
Revenue $.12M $.12M $.11M
Gross Profit
Net Income / Loss $-11.26M $-13.94M $-13.43M
Operating Income / Loss $-11.97M $-14.78M $-14.38M
Cost of Revenue
Net Cash Flow $-.65M $-13.31M $-27.38M
PE Ratio    
Splits
Feb 20, 2019 1:6
Jun 04, 2018 1:12
May 30, 2012 1:6